5Month27In the afternoon, the "Opportunities and Challenges of the Medical Device Industry in the Post-epidemic Era" Summit Forum hosted by Nanjing Medical Device Management Association and hosted by Nanjing Shuangwei Biomedical Technology Co., Ltd. (hereinafter referred to as Shuangwei Biology) focused on the future of the medical device industry in the post-epidemic era, shared the innovative achievements, development trends and opportunities of the medical device industry, and exchanged views and thoughts. He Guangming, Executive Chairman of Nanjing Medical Device Management Association, Chairman (legal representative), Leng Derong, President of Nanwei Medical Technology Co., Ltd., Executive Vice President and Secretary-General of the Association, Chairman of Nanjing Shuangwei Biomedical Technology Co., Ltd. Xiao Guofeng, Vice President, Deputy Secretary-General of the Association, Vice President, Secretary-General of the Circulation Branch and other entrepreneur representatives, as well as the middle and senior managers of Shuangwei Biology gathered together to enjoy a gluttoness of thinking.

Cai Huiming, chairman of Nanjing Life Source Pharmaceutical Industry Co., Ltd., Shu Zhiqiang, chairman of Nanjing Great Wall Information System Co., Ltd., pan Xiubing, chairman of Nanjing Yanchang Medical Device Third Party Logistics Co., Ltd., Yu Jianyong, general manager of Nanjing Kejin Industrial Co., Ltd., Ding Haibo, chairman of Nanjing Bayden Medical Co., Ltd., and Yang Yirong, secretary general of circulation branch and chairman of Nanjing Weisheng Education Technology Co., Ltd, liu Beibei, general manager of Nanjing Wenbei Medical Products Co., Ltd., vice chairman of the circulation branch, Shen Huaguo, general manager of Jiangsu Hecheng Biotechnology Co., Ltd., Zhang Lirong, deputy secretary general of the association, party branch secretary of Nanwei Medical Technology Co., Ltd., Meng Wenjie, director of the association office, He Renhai, secretary general of Nanjing Jingzhou Chamber of Commerce, attended the forum.

Cha Xuemin, director of Shuangwei Biology Office, served as the host of this forum.

Kang Linlin, Vice Minister of Sunway Biological Marketing Department, introduced the company's general situation, strategic positioning, main products, scientific and technological research and development, market development, corporate culture and so on.

As engaged in the Internet industry10Year, medicaltherapeutic device industry5Cross-border entrepreneurs in, not long ago just completed the billion yuan levelBRound of financing, founder andCEODing Haibo made a wonderful exposition on the theme of "Opportunities and Challenges for the Medical Device Industry in the Post-Epidemic Era.

Ding shared a series of work done by Beden Medical in response to the new crown epidemic, in the face of adversity from the perspective of corporate governance structure, after analyzing that the golden decade of China's medical devices has just begun, and the medical device health industry is China's future.20The largest social wealth gathering mouth, the new crown epidemic is to accelerate the development of the industry. The impact of the new crown epidemic on global politics, economy, industry and landscape is very large, and Ding believes that the greater the crisis, the greater the opportunity. In the face of a major crisis, the test of a person or enterprise is not regular competitiveness, but the ability to respond to the crisis of rapid adjustment. As2019At the end of the year, the total number of medical institutions in China has reached100Wanjia, and presents the characteristics of diversified and unbalanced development. International first-line brands to control the mature market of tertiary hospitals, customer concentration, easy coverage and service, is the mainstream mature market. Under the background of graded diagnosis and treatment, China's new medical institutions95%The above are concentrated in the grass-roots and private, the vast grass-roots and private medical market has become an emerging blue ocean market. China's medical device marketing is accelerating into the online, video era. Medical equipment manufacturers are facing the huge challenge of how to quickly cover a large number of blank markets and emerging markets, and it is imperative for enterprises to change their marketing and sales channels. The four major development trends of China's medical device circulation: First, medical insurance control fees drive the continuous price reduction of hospital procurement. Mr. Ding said that Beden Medical hopes to meet more partners to change China's medical and health industry, strengthen confidence, innovate and seek change, and win-win cooperation, whether it is in the domestic Internet circulation and trade, or the acceleration of the entire digital process, as well as overseas operations.

Cai Huiming, a science and technology entrepreneurship mentor and industry professor in Jiangsu Province (Nanjing University) with more than 20 years of successful entrepreneurship and business management experience, and chairman of Nanjing Life Source Pharmaceutical Industry Co.

Cai Dong thought and discussed the innovation of medical devices from four aspects: first, the "danger" and "machine" of the medical device industry; second, the new requirements for innovation and development in the new era; third, the discussion of innovation mode by Nuoyuan medical; fourth, the discussion of innovative products by Nuoyuan medical.

When analyzing the current situation of China's medical device industry, Cai Dong pointed out that under the influence of the new crown epidemic, high-value consumables and related equipment for surgery were under obvious pressure during the epidemic. Low-value consumables are short-term shortage, and overcapacity may occur in the later period. Non-rigid consumption of medical care such as medical beauty and oral cavity; Inventory backlog, rent and labor costs rise; The superposition effect of purchasing with quantity, these factors lead to some enterprises facing elimination. However, advantageous enterprises are bound to increase technological innovation and accelerate to seize the market. More and more enterprises with stronger resource integration ability have strong cross-border, which further compresses the living space of small and medium-sized enterprises. High-end medical devices mainly rely on imports is still a long-standing problem. Cai Dong believes that the current medical device industry "danger" is the lack of competitiveness of the industry, and the new crown epidemic brought about by the opportunities and the new era of empowerment, so that the medical equipment industry shows a good momentum of development, the next decade will still be China's medical device industry rapid development of the golden period, this is the opportunity. The new era has proposed import substitution for the innovative development of medical devices; accelerating the transformation of scientific and technological achievements and increasing the conversion rate; offline+New requirements such as a shift in the online marketing mix model.The medical device industry should strive to cultivate new machines in the crisis, open new games in the changing situation, and seek development through innovation.

Nanjing Nuoyuan Medical Devices Co., Ltd. is a wholly-owned medical device company invested by Nanjing Life Source Pharmaceutical Industry Co., Ltd. After more than four years of development, it has been committed to technological innovation, product innovation and model innovation. Nuoyuan Medical is committed to becoming the world's leader in precision surgery technology by innovation and excellence and sincerity. Cai Dong deeply and comprehensively introduced Nuoyuan Medical's unremitting pursuit and exploration of innovative models and innovative products from the aspects of elite team introduction, efficient collaboration model, government funding and promotion, core technology, and main products.

As the first state company listed on the board in Nanjing.Leng Derong, a special allowance expert in the hospital and president of Nanwei Medical Technology Co., Ltd., gave a vivid and incisive explanation on the theme of "New Medical Reform Situation and Enterprise Countermeasures.

President Leng explained the understanding of China's medical reform in simple terms from the impact of the epidemic, the latest medical insurance trends, the basic logic of the new medical reform, the basic policies of the new medical reform, the volume of procurement, the understanding of the new medical reform, the business-level response measures, the company-level response measures, the work flow and key points of the access department, etc., analyzed the new medical reform situation, interpreted the new medical reform policy, and provided advice for enterprises.

He Guangming, executive chairman of Nanjing Medical Device Management Association, spoke highly of the holding of the summit forum and the wonderful sharing of the three industry giants. In his final speech, President Ho pointed out what we should do in the post-epidemic era? The first is to change our concepts, from the changes in our lifestyle habits to the changes in the national disease control system and emergency management system; the second is to innovate, innovation is the source of development, and there must be innovative ideas and innovative teams; The third is to study and learn. Whether it is a production enterprise or a business enterprise, it must promptly understand and master the new policies and regulations of national development, and adapt to the new situation and new requirements, adapt to the development environment, adapt to the regulatory environment, adapt to the social needs of the environment. President He said that in the future, the work of the association should be carried out more practically. We should not only discuss and exchange among the executive directors, but also go to enterprises to hold such forums and carry out exchanges. The departments of different enterprises can also communicate more to form a good atmosphere.